Dubai PR Network, Online Press Release from Dubai and Middle East
 
Health & Fitness(Healthcare & Medicine)
Filter PR by
  
FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product
 

Dubai, United Arab Emirates, July 08, 2020:  The U.S. Food and Drug Administration (FDA) today authorized the marketing of IQOS, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health.

- Today’s decision demonstrates that IQOS is a fundamentally different tobacco product and a better choice for adults who would otherwise continue smoking
- IQOS is the first and only electronic nicotine product to be granted marketing orders through the FDA’s MRTP process
- The FDA authorized the marketing of IQOS with the following information:
- The IQOS System heats tobacco but does not burn it
- This significantly reduces the production of harmful and potentially harmful chemicals
- Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system reduces your body’s exposure to harmful or potentially harmful chemicals.
- The agency concluded that the available scientific evidence demonstrates that IQOS is expected to benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products
- The FDA’s decision further builds on the emerging independent international scientific consensus that IQOS is a better choice than continuing to smoke, and follows the FDA’s April 2019 decision authorizing the commercialization of IQOS in the U.S.
- The FDA’s decision provides an important example of how governments and public health organizations can regulate smoke-free alternatives to differentiate them from cigarettes in order to protect and promote the public health

 


This decision follows a review of the extensive scientific evidence package PMI submitted to the FDA in December 2016 to support its MRTP applications.
Commenting on the FDA’s announcement, André Calantzopoulos, PMI’s Chief Executive Officer, said:
“The FDA’s decision is a historic public health milestone. Many of the tens of millions of American men and women who smoke today will quit—but many won’t. Today’s decision makes it possible to inform these adults that switching completely to IQOS is a better choice than continuing to smoke. FDA determined that scientific studies show that switching completely from conventional cigarettes to IQOS reduces exposure to harmful or potentially harmful chemicals.
IQOS is a fundamentally different product than combustible cigarettes and must be regulated differently, as the FDA has recognized. Now—more than ever—there is an urgent need for a fundamentally different conversation on a cooperative approach to achieve a smoke-free future. The FDA’s decision provides an important example of how governments and public health organizations can regulate smoke-free alternatives to differentiate them from cigarettes in order to promote the public health.


We are excited that this important decision will help guide the choices of adult smokers in the U.S. The best choice for health is to never start smoking or to quit altogether. For those who don’t quit, the best thing they can do is switch to a scientifically substantiated smoke-free product. As of March 31, 2020, PMI estimates that approximately 10.6 million adult smokers around the world have already stopped smoking and switched to IQOS. We believe that this decision can help to further accelerate the transition of U.S. adults away from cigarettes. We, along with our licensee Altria, are committed to guarding against unintended use and fully support FDA’s focus on protecting youth.


Today’s decision is a result of our ongoing commitment to put science at the forefront as we continue on our quest to replace cigarettes with smoke-free alternatives as quickly as possible.


We look forward to working with the FDA to provide any additional information they may require in order to market IQOS with reduced risk claims.
Harnessing innovations like IQOS to dramatically speed-up the decline in cigarette smoking is the opportunity of this century. Comprehensive, science-based regulation can help to rapidly shift adult smokers who would otherwise continue smoking to better options, while simultaneously guarding against unintended consequences.”


Posted by : Dubai PR Network Editorial Team
Viewed 5014 times
PR Category : Healthcare & Medicine
Posted on : Wednesday, July 8, 2020  12:52:00 PM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Traveler Survey Reveals COVID-19 Concerns
Next Story : Honeywell Announces Solutions to Help Improve Building Healt...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Make Up for Ever Introduces for the First Time Its New Active Care-in-foundation to Revive... [5293-Views]
HONOR 2020 H1 Business Achievements in International Markets [3087-Views]
Save up to AED 25,000 on Pre-Owned Lexus Cars with Al-Futtaim Auto Fest [2858-Views]
Panasonic Jaguar Racing Head to Berlin for a Lockdown Showdown [2854-Views]
Here's Why A Silicone Cleansing Brush Champions Other Cleansing Tools and Techniques [2772-Views]
Safe Start-up of Unit 1 of Barakah Nuclear Energy Plant Successfully Achieved [2759-Views]
Samsung Launches Galaxy Watch3 and Galaxy Buds Live [2628-Views]
Schneider Electric Shows They Are Acting to Build a Green and Inclusive Future for All Thr... [2530-Views]
Sony Middle East & Africa Announces ‘Ready for PlayStation®5' for current BRAVIA™ TVs [2255-Views]
UAE Team Emirates Back to Winning Ways [2218-Views]
Lacoste Launches the Roland - Garros Eyewear Collection [2099-Views]
Jafza Sets a New Benchmark With ‘collaboration for Safe and Sustainable Growth' Webinar' [2062-Views]
Win Big at Dalma Mall with the ‘Eid Family Shopping Challenge' [2054-Views]
Introducing the New Omega Constellation Gents' Collection' [1935-Views]
Dubai Sports Council and Ski Dubai to Host One of the World's First Snow Sports Competitio... [1800-Views]
Pre-Orders for Samsung's Galaxy Note20 and Galaxy Note20 Ultra Now Open in the UAE [1792-Views]
The Last Few Weeks of Dubai Shopping Mall Group's Summer Promotion [1714-Views]
Cebu Pacific Advisory: Suspension of Domestic Passenger Flights to/from Manila – Aug 4 to ... [1706-Views]
No Premium Without Responsibility: BMW Group Makes Sustainability and Efficient Resource M... [1673-Views]
Post-COVID Travel is Set to Become Smarter. Here's How. [1628-Views]
DREI Organises Virtual Real Estate Conference With Saudi Partners [1628-Views]
Etihad Airways Introduces Microbebarrier™ Face Protection for Premium Passengers [1611-Views]
RAKEZ Welcomes 100% Foreign Ownership in Mainland with FDI Company Set-Up [1603-Views]
LG Announces Second-Q2020 Financial Results [1599-Views]
Sharjah Shopping Promotions Draws a Smile on Faces of 3 Lucky Winners of (BMW – X2) [1583-Views]
 
RSS Facebook Twitter LinkedDin
 
Top Sections
 
Top Stories